Crystalline bromodomain inhibitors
- 专利权人:
- AbbVie Inc.
- 发明人:
- Gong, Yuchuan
- 申请号:
- AU2014302252
- 公开号:
- AU2014302252A1
- 申请日:
- 2014.06.27
- 申请国别(地区):
- AU
- 年份:
- 2015
- 代理人:
- 摘要:
- N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3- c]pyridin-4-yl)phenyl]ethanesulfonamide and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- BENZIMIDAZOLONE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USES THEREOF IN THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF CONDITIONS MEDIATED BY 5-HT4 RECEPTOR ACTIVITY
- ЛЕКАРСТВЕННАЯ КОМПОЗИЦИЯ ЦИТОПРОТЕКТОРНОГО ДЕЙСТВИЯ В ВИДЕ ВОДНОГО РАСТВОРА ДЛЯ ВНУТРИВЕННОГО ВВЕДЕНИЯ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ
- Lysophosphatidic acid receptor antagonists
- LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS
- LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS